Annual report pursuant to Section 13 and 15(d)

Segments (Tables)

v2.4.1.9
Segments (Tables)
12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Information regarding our geographic activities
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the years ended December 31,
(In thousands)
2014
 
2013
 
2012
Product revenues:
 
 
 
 
 
Pharmaceuticals
$
76,983

 
$
68,161

 
$
45,295

Diagnostics

 

 

Corporate

 

 

 
$
76,983

 
$
68,161

 
$
45,295

Revenue from services:
 
 
 
 
 
Pharmaceuticals
$

 
$

 
$

Diagnostics
8,426

 
10,833

 
395

Corporate
240

 
825

 
1,354

 
$
8,666

 
$
11,658

 
$
1,749

Revenue from transfer of intellectual property:
 
 
 
 
 
Pharmaceuticals
$
5,285

 
$
15,160

 
$

Diagnostics
191

 
1,551

 

Corporate

 

 

 
$
5,476

 
$
16,711

 
$

Operating (loss) income:
 
 
 
 
 
Pharmaceuticals
$
(94,401
)
 
$
(29,809
)
 
$
(6,797
)
Diagnostics
(21,647
)
 
(22,199
)
 
(14,259
)
Corporate
(27,725
)
 
(24,473
)
 
(15,628
)
Less: Operating loss attributable to noncontrolling interests
(2,042
)
 
(3,151
)
 
(585
)
 
$
(145,815
)
 
$
(79,632
)
 
$
(37,269
)
Depreciation and amortization:
 
 
 
 
 
Pharmaceuticals
$
7,936

 
$
8,234

 
$
6,367

Diagnostics
6,894

 
6,833

 
3,614

Corporate
97

 
149

 
179

 
$
14,927

 
$
15,216

 
$
10,160

Net loss from investment in investees:
 
 
 
 
 
Pharmaceuticals
$
(3,587
)
 
$
(11,456
)
 
$
(2,062
)
Diagnostics

 

 

Corporate

 

 

 
$
(3,587
)
 
$
(11,456
)
 
$
(2,062
)
Revenues:
 
 
 
 
 
United States
$
14,142

 
$
28,369

 
$
1,749

Chile
29,154

 
31,650

 
26,514

Spain
21,323

 
18,800

 
6,124

Israel
20,638

 
13,252

 
7,655

Mexico
5,807

 
4,459

 
5,002

Other
61



 

 
$
91,125

 
$
96,530

 
$
47,044


(In thousands)
December 31,
2014
 
December 31,
2013
Assets:
 
 
 
Pharmaceuticals
$
1,064,498

 
$
1,065,033

Diagnostics
108,072

 
116,944

Corporate
95,094

 
209,539

 
$
1,267,664

 
$
1,391,516

Goodwill:
 
 
 
Pharmaceuticals
$
173,327

 
$
175,408

Diagnostics
50,965

 
50,965

Corporate

 

 
$
224,292

 
$
226,373